Inhibitory effect of Lactobacillus gasseri TMC0356 and Lactobacillus GG on enhanced vascular permeability of nasal mucosa in experimental allergic rhinitis of rats

Bioscience, Biotechnology and Biochemistry

Volumn 70, Issue 12, 2006, Pages 3025-3030

  Kawase, Manabu ^a   He, Fang ^a   Kubota, Akira ^a   Hata, Jun Ya ^b   Kobayakawa, Shin Ichiro ^b   Hiramatsu, Masaru ^a  

^a Yokohama Kanagawa   (Japan)

^b TOHO UNIVERSITY   (Japan)

Author keywords

Allergic rhinitis; Lactobacillus; Probiotic; Vascular permeability

Indexed keywords

ALLERGIES; BACTERIA; CONCENTRATION (PROCESS); ENZYME INHIBITION; STATISTICAL METHODS;

ALLERGIC RHINITIS; LACTOBACILLUS; NASAL VASCULAR PERMEABILITY; PROBIOTIC;

LIVING SYSTEMS STUDIES;

ANIMAL; ARTICLE; CAPILLARY PERMEABILITY; LACTOBACILLUS; MALE; NOSE MUCOSA; PERENNIAL RHINITIS; RAT; VASCULARIZATION;

ANIMALS; CAPILLARY PERMEABILITY; LACTOBACILLUS; MALE; NASAL MUCOSA; RATS; RHINITIS, ALLERGIC, PERENNIAL;

LACTOBACILLUS; LACTOBACILLUS GASSERI; RATTUS NORVEGICUS;

EID: 33845900506     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.60152     Document Type: Article

References (24)

1. Abbas, A. K., and Lichtman, A. H., "Basic Immunology: Functions and Disorders of the Immune System," W. B. Saunders, Philadelphia, pp. 167-284 (2001).
2. Peakman, M., and Vergani, D., "Basic and Clinical Immunology," Churchill Liveingstone, Hong Kong, pp. 131-146 (1997).
3. Fuller, R., Probiotics in man and the animals. J. Appl. Bacteriol., 66, 356-378 (1989).
4. Salminen, S., Ouwehand, A., Benno, Y., and Lee, Y. K., Probiotics: how should they be defined? Trends Food Sci. Technol., 10, 107-110 (1999).
5. Kalliomäki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P., and Isolauri, E., Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet, 357, 1076-1079 (2001).
6. Kalliomäki, M., Salminen, S., Poussa, T., Arvilommi, H., and Isolauri, E., Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet, 361, 1869-1871 (2003).
7. Fujiwara, D., Wakabayashi, H., Watanabe, H., Nishida, S., and Iino, H., A double-blind trial of Lactobacillus paracasei strain KW3110 administration for immunomodulation in patients with pollen allergy. Allergol. Int., 54, 143-149 (2005).
8. Ishida, Y., Nakamura, F., Kanzato, H., Sawada, D., Hirata, H., Nishimura, A., Kajimoto, O., and Fujiwara, S., Clinical effects of Lactobacillus acidophilus strain L-92 on perennial allergic Rhinitis: a double-blind, placebo-controlled study. J. Dairy Sci., 88, 527-533 (2005).
9. Ishida, Y., Nakamura, F., Kanzato, H., Sawada, D., Yamamoto, N., Kagata, H., Oh-ida, M., Takeuchi, H., and Fujiwara, S., Effect of milk fermented with Lactobacillus acidophilus strain L-92 on symptoms of Japanese cedar pollen allergy: a randomized placebo-controlled trial. Biosci. Biotechnol. Biochem., 69, 1652-1660 (2005).
10. Kojima, M., Tsutsumi, N., Abe, M., Komatsu, H., Ujiie, A., Naito, J., and Nakazawa, M., Experimental allergic rhinitis in rats and the influence of tranilast and antihistaminics on it. Japan. J. Allergol., 35, 180-187 (1986).
11. Albert, D. H., Tapang, P., Morgan, D. W., Curtin, M. L., Sheppard, G. S., Davidsen, S. K., Summers, J. B., and Carter, G. W., ABT-491, a highly potent and selective PAF antagonist, inhibits nasal vascular permeability associated with experimental allergic rhinitis in Brown Norway rats. Inflamm. Res., 46, S133-S134 (1997).
12. Mizuno, H., Kawamura, Y., Iwase, N., and Ohno, H., Effects of Flutropium on experimental models of drug-and allergy-induced rhinitis in guinea pigs. Jpn. J. Pharmacol., 55, 321-328 (1991).
13. Okuda, M., Ishikawa, T., and Konno, A., Mechanisms of allergic rhinitis. In "Clinical Guideline for Allergic Rhinitis in Japan: Perennial and Seasonal Allergic Rhinitis. Establishment Committee of the Clinical Guideline for Allergic Rhinitis" 4th ed. (in Japanese), eds. Okuda, M., Baba, K., Konno, A., and Takenaka, H., Life Science, Tokyo, pp. 14-16 (2002).
14. Pessi, T., Sütas, Y., Hurme, M., and Isolauri, E., Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin. Exp. Allergy, 30, 1804-1808 (2000).
15. Rautava, S., Kalliomaki, M., and Isolauri, E., Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J. Allergy Clin. Immunol., 109, 119-121 (2002).
16. Helin, T., Haahtela, S., and Haahtela, T., No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study. Allergy, 57, 243-246 (2002).
17. Hosoda, M., Hashimoto, H., Yamazaki, K., He, F., and Hosono, A., Inhibitory effects of fecal Lactobacilli and Bifidobacteria on the mutagenicities of Trp-P-2 and IQ. Milchwissenschaft, 53, 309-313 (1998).
18. Morita, H., He, F., Fuse, T., Ouwehand, A. C., Hashimoto, H., Hosoda, M., Mizumachi, K., and Kurisaki, J., Cyokine production by the murine macrophage cell line J774.1 after exposure to lactobacilli. Biosci. Biotechnol. Biochem., 66, 1963-1966 (2002).
19. Morita, H., He, F., Kawase, M., Kubota, A., Hiramatsu, M., Kurizaki, J., and Salminen, S., Preliminary human study for possible alteration of serum immunoglobulin E production in perennial allergic rhinitis with fermented milk prepared with Lactobacillus gasseri TMC0356. Microbiol. Immunol., 50, 701-706 (2006).
20. Iliev, I. D., Kitazawa, H., Shimosato, T., Katoh, S., Morita, H., He, F., Hosoda, M., and Saito, T., Strong immunostimulation in murine immune cells by Lactobacillus rhamnosus GG DNA containing novel oligodeoxynucleotide pattern. Cell. Microbiol., 7, 403-414 (2005).
21. Mohamadzadeh, M., Olson, S., Kalina, W. V., Ruthel, G., Demmin, G. L., Waffield, K. L., Bavari, S., and Klaenhammer, T. R., Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc. Natl. Acad. Sci. USA, 102, 2880-2885 (2005).
22. Iijima, H., Tamura, G., Hsiue, T., Liu, Y., Taniguchi, H., and Shirato, K., Suplatast tosilate inhibits late response and airway inflammation in sensitized guinea pigs. Am. J. Respir. Crit. Care Med., 160, 331-335 (1999).
23. Konno, S., Adachi, M., Asano, K., Gonogami, Y., Ikeda, K., Okamoto, K., and Takahashi, T., Suppressive effects of IPD-1151T (suplatast-tosilate) on induction of mast cells from normal mouse splenocytes. Eur. J. Pharmacol., 259, 15-20 (1994).
24. Fujiwara, T., Clinic and base of immunomodulation system antiallergic agent tosyl acid supratast (IPD capsule) which peculiarly suppresses IgE antibody formation. Shin-yaku to Rinsho (in Japanese), 45, 283-306 (1996).